Dihydrotachysterol

TargetMol
Product Code: TAR-T21417
Supplier: TargetMol
CodeSizePrice
TAR-T21417-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21417-50mg50mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Dihydrotachysterol (DHT) is a biologically active synthetic analog of vitamin D. It promotes intestinal absorption of active calcium and phosphate . It is also beneficial in the treatment of hypoparathyroidism.
CAS:
67-96-9
Formula:
C28H46O
Molecular Weight:
398.675
Purity:
0.98
SMILES:
[H][C@@]12CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CCCC2=C/C=C1C[C@@H](O)CC[C@@H]1C

References

1. Voigts AL, Felsenfeld AJ, Llach F. The effects of calciferol and its metabolites on patients with chronic renal failure. I. Calciferol, dihydrotachysterol, and calcifediol. Arch Intern Med. 1983 May;143(5):960-3. Review. PubMed PMID: 6089682. 2. Quack I, Zwernemann C, Weiner SM, Sellin L, Henning BF, Waldherr R, B?chner NJ, Stegbauer J, Vonend O, Rump LC. Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review. Exp Clin Endocrinol Diabetes. 2005 Jul;113(7):376-80. Review. PubMed PMID: 16025398. 3. Kaiser W, Mampel E. [New viewpoints on the therapy and prevention of renal osteopathy]. Z Gesamte Inn Med. 1977 Jun 15;32(12):254-9. Review. German. PubMed PMID: 333796. 4. NORDIO S, ANTENER I. [RICKETS. METABOLIC, NOSOLOGICAL, PREVENTIVE AND THERAPEUTIC PROBLEMS]. Minerva Pediatr. 1963 Aug 25;15:849-90. Review. Italian. PubMed PMID: 14087868.